NCT01276301View on ClinicalTrials.gov

DDI Between BI Empagliflozin (10773) and Verapamil

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

February 28, 2011

Conditions
Healthy
Interventions
DRUG

Verapamil

single dose verapamil

DRUG

BI 10773

single dose BI 10773

DRUG

BI 10773

single dose BI 10773

Trial Locations (1)

Unknown

1245.43.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY